Our findings reveal that CD14++ monocytes from these patients exhibit profound bioenergetic impairment, defective oxidative stress adaptation, elevated mitochondrial membrane potential, and region-specific mtDNA damage, offering mechanistic insights into the pathophysiology of PASC-related cardiovascular sequelae. The gene discussed is CD14; the disease is long COVID-19.